英文名稱 | Tofacitinib Citrate | Tasocitinib Citrate | CP-690550 Citrate |
---|---|
中文名稱 | 枸櫞酸托法替尼丨枸櫞酸托法替布 |
CAS號 | 540737-29-9 |
分子式 | C16H20N6O.C6H8O7 |
分子量 | 504.49 |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
英文名稱 | Tofacitinib Citrate | Tasocitinib Citrate | CP-690550 Citrate |
---|---|
中文名稱 | 枸櫞酸托法替尼丨枸櫞酸托法替布 |
CAS號 | 540737-29-9 |
分子式 | C16H20N6O.C6H8O7 |
分子量 | 504.49 |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Tofacitinib, also known as tasocitinib, CP-690550, is a Janus kinase (JAK) inhibitor. Tofacitinib modulates the signaling pathway at the point of JAKs, preventing the phosphorylation and activation of STATs. JAK enzymes transmit cytokine signaling through pairing of JAKs (e.g., JAK1/JAK3, JAK1/JAK2, JAK1/TyK2, JAK2/JAK2). Tofacitinib inhibited the in vitro activities of JAK1/JAK2, JAK1/JAK3, and JAK2/JAK2 combinations with IC50 of 406, 56, and 1377 nM, respectively.